These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37972955)

  • 21. Relationship of Topographic Distribution of Geographic Atrophy to Visual Acuity in Nonexudative Age-Related Macular Degeneration.
    Shen LL; Sun M; Ahluwalia A; Young BK; Park MM; Toth CA; Lad EM; Del Priore LV
    Ophthalmol Retina; 2021 Aug; 5(8):761-774. PubMed ID: 33212271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy for neovascular age-related macular degeneration.
    Evans JR; Igwe C; Jackson TL; Chong V
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004004. PubMed ID: 32844399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
    Jaffe GJ; Westby K; Csaky KG; Monés J; Pearlman JA; Patel SS; Joondeph BC; Randolph J; Masonson H; Rezaei KA
    Ophthalmology; 2021 Apr; 128(4):576-586. PubMed ID: 32882310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
    Heier JS; Lad EM; Holz FG; Rosenfeld PJ; Guymer RH; Boyer D; Grossi F; Baumal CR; Korobelnik JF; Slakter JS; Waheed NK; Metlapally R; Pearce I; Steinle N; Francone AA; Hu A; Lally DR; Deschatelets P; Francois C; Bliss C; Staurenghi G; Monés J; Singh RP; Ribeiro R; Wykoff CC;
    Lancet; 2023 Oct; 402(10411):1434-1448. PubMed ID: 37865470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in Central Serous Chorioretinopathy Following Multiwavelength Photobiomodulation Treatment - Case Report.
    Sachdev A
    Ophthalmol Ther; 2024 Jul; 13(7):2055-2060. PubMed ID: 38758517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
    Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
    Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial.
    Rosenfeld PJ; Dugel PU; Holz FG; Heier JS; Pearlman JA; Novack RL; Csaky KG; Koester JM; Gregory JK; Kubota R
    Ophthalmology; 2018 Oct; 125(10):1556-1567. PubMed ID: 29716784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
    Liao DS; Grossi FV; El Mehdi D; Gerber MR; Brown DM; Heier JS; Wykoff CC; Singerman LJ; Abraham P; Grassmann F; Nuernberg P; Weber BHF; Deschatelets P; Kim RY; Chung CY; Ribeiro RM; Hamdani M; Rosenfeld PJ; Boyer DS; Slakter JS; Francois CG
    Ophthalmology; 2020 Feb; 127(2):186-195. PubMed ID: 31474439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.
    Wykoff CC; Rosenfeld PJ; Waheed NK; Singh RP; Ronca N; Slakter JS; Staurenghi G; Monés J; Baumal CR; Saroj N; Metlapally R; Ribeiro R
    Ophthalmology; 2021 Sep; 128(9):1325-1336. PubMed ID: 33711380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.
    ; Huynh N; Nicholson BP; Agrón E; Clemons TE; Bressler SB; Rosenfeld PJ; Chew EY
    Ophthalmology; 2014 Jun; 121(6):1229-36. PubMed ID: 24613825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration.
    Wu Z; Ayton LN; Luu CD; Guymer RH
    JAMA Ophthalmol; 2015 Apr; 133(4):442-8. PubMed ID: 25632841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
    Age-Related Eye Disease Study Research Group
    Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration.
    Kim MS; Ryoo NK; Park KH
    Sci Rep; 2020 Sep; 10(1):14370. PubMed ID: 32873842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
    Holekamp N; Wykoff CC; Schmitz-Valckenberg S; Monés J; Souied EH; Lin H; Rabena MD; Cantrell RA; Henry EC; Tang F; Swaminathan B; Martin J; Ferrara D; Staurenghi G
    Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Baseline Quantitative OCT Features on Response to Risuteganib for the Treatment of Dry Age-Related Macular Degeneration: The Importance of Outer Retinal Integrity.
    Abraham JR; Jaffe GJ; Kaiser PK; Chiu SJ; Loo J; Farsiu S; Bouckaert L; Karageozian V; Sarayba M; Srivastava SK; Ehlers JP
    Ophthalmol Retina; 2022 Nov; 6(11):1019-1027. PubMed ID: 35569763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000254. PubMed ID: 28756618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aflibercept for neovascular age-related macular degeneration.
    Sarwar S; Clearfield E; Soliman MK; Sadiq MA; Baldwin AJ; Hanout M; Agarwal A; Sepah YJ; Do DV; Nguyen QD
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011346. PubMed ID: 26857947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging Therapies in Nonexudative Age-Related Macular Degeneration in 2020.
    Samanta A; Aziz AA; Jhingan M; Singh SR; Khanani AM; Chhablani J
    Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(4):408-416. PubMed ID: 33512911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical Trial.
    Boyer DS; Gonzalez VH; Kunimoto DY; Maturi RK; Roe RH; Singer MA; Xavier S; Kornfield JA; Kuppermann BD; Quiroz-Mercado H; Aubel J; Karageozian HL; Park JY; Karageozian VH; Karageozian L; Sarayba MA; Kaiser PK
    Ophthalmic Surg Lasers Imaging Retina; 2021 Jun; 52(6):327-335. PubMed ID: 34185587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.